COLL vs FTNT · P/E 17, rev $181.9M vs P/E 56, rev $6.80B
Collegium Pharmaceutical Inc (COLL) versus Fortinet Inc (FTNT) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Fortinet Inc (FTNT) is a software - infrastructure company listed on NASDAQ.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported FTNT revenue for 2025-12-31 was $6.80B. Net income was $1.85B. Revenue was up 14.2% from 2024-12-31 to 2025-12-31. FTNT currently screens at market cap $105.60B and trailing P/E 56.1.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. FTNT currently screens at market cap $105.60B and trailing P/E 56.1.
Not investment advice. Open the COLL and FTNT stock pages for the full models.
Not investment advice.